Know Cancer

or
forgot password
  • cancer clinical trials in whittier, CA

  • Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Breast Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Metastatic Cancer, Prostate Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Breast Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Agajanian Institute of Oncology and Hematology
    Whittier, California 90602
    Prostate Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Lung Cancer
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    American Institute of Research
    Whittier, California 90603
    Renal Cell Carcinoma
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Kidney Cancer
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10039 Boehringer Ingelheim Investigational Site
    Whittier, California
    Breast Neoplasms
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Colorectal Cancer
    Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer
    American Institute of Research
    Whittier, California 90603
    Non-Squamous Non-Small Cell Lung Cancer
    CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
    The Oncology Institute of Hope and Innovation
    Whittier, California 90606
    Chronic Myelogenous Leukemia in Chronic Phase
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    American Institute of Research
    Whittier, California 90603
    Non Small Cell Lung Cancer
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Breast Cancer
    Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission
    Innovative Clinical Research Institute, LLC
    Whittier, California 90603
    Leukemia, Myeloid, Acute
    Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
    Oncology Institute of Hope & Innovation, The
    Whittier, California 90603
    Hodgkin Disease
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Ruby L. Golleher Cancer Program at Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Pancreatic Cancer
    Usefulness of Acupuncture in Cancer Pain and Quality of Life
    Southern California University of Health Sciences
    Whittier, California 90604
    Cancer, Pain
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Presbyterian Intercommunity Hospital
    Whittier, California 90602
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer
    American Institute of Research
    Whittier, California 90603
    Non-small-cell Lung Cancer
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    American Institute of Research
    Whittier, California 90603
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    Agajanian Institute of Oncology and Hematology

    Trial Locations
    Agajanian Institute of Oncology and Hematology
    American Institute of Research
    Chemotherapy-Induced Nausea and Vomiting